These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 28123160)
1. Effects of Statins and Xuezhikang on the Expression of Secretory Phospholipase A2, Group IIA in Rat Vascular Smooth Muscle Cells. Xie Q; Zhang D Int Heart J; 2017 Feb; 58(1):115-124. PubMed ID: 28123160 [TBL] [Abstract][Full Text] [Related]
2. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs. El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6. Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795 [TBL] [Abstract][Full Text] [Related]
4. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells. Jaulmes A; Janvier B; Andreani M; Raymondjean M Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1161-7. PubMed ID: 15802623 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation. Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818 [TBL] [Abstract][Full Text] [Related]
6. Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. Jaulmes A; Thierry S; Janvier B; Raymondjean M; Maréchal V FASEB J; 2006 Aug; 20(10):1727-9. PubMed ID: 16807371 [TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats. Vlachojannis GJ; Scholz-Pedretti K; Fierlbeck W; Geiger H; Pfeilschifter J; Kaszkin M Clin Nephrol; 2005 May; 63(5):356-67. PubMed ID: 15909595 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta-induced type IIA secreted phospholipase A2 gene expression and extracellular activity in rat vascular endothelial cells. Schwemmer M; Aho H; Michel JB Tissue Cell; 2001 Jun; 33(3):233-40. PubMed ID: 11469536 [TBL] [Abstract][Full Text] [Related]
9. Oleanolic acid protects against cognitive decline and neuroinflammation-mediated neurotoxicity by blocking secretory phospholipase A2 IIA-activated calcium signals. Zhang L; Xia R; Jia J; Wang L; Li K; Li Y; Zhang J Mol Immunol; 2018 Jul; 99():95-103. PubMed ID: 29747052 [TBL] [Abstract][Full Text] [Related]
10. Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells. Menschikowski M; Hagelgans A; Heyne B; Hempel U; Neumeister V; Goez P; Jaross W; Siegert G Biochim Biophys Acta; 2005 Apr; 1733(2-3):157-71. PubMed ID: 15863363 [TBL] [Abstract][Full Text] [Related]
11. Statin therapy and secretory phospholipase A₂ in children with heterozygous familial hypercholesterolemia. Braamskamp MJ; Tsimikas S; Wiegman A; Kastelein JJ; Hutten BA Atherosclerosis; 2013 Aug; 229(2):404-7. PubMed ID: 23880195 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium. Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014 [TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X. Pruzanski W; Kopilov J; Kuksis A Prostaglandins Other Lipid Mediat; 2016 Jan; 122():64-8. PubMed ID: 26711221 [TBL] [Abstract][Full Text] [Related]
14. Group IIA Secretory Phospholipase A Akinkuolie AO; Lawler PR; Chu AY; Caulfield M; Mu J; Ding B; Nyberg F; Glynn RJ; Ridker PM; Hurt-Camejo E; Chasman DI; Mora S Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1182-1190. PubMed ID: 31070471 [TBL] [Abstract][Full Text] [Related]
15. Cross-talk between group IIA-phospholipase A2 and inducible NO-synthase in rat renal mesangial cells. Rupprecht G; Scholz K; Beck KF; Geiger H; Pfeilschifter J; Kaszkin M Br J Pharmacol; 1999 May; 127(1):51-6. PubMed ID: 10369455 [TBL] [Abstract][Full Text] [Related]
17. Diverse activity of human secretory phospholipases A2 on the migration of human vascular smooth muscle cells. Pruzanski W; Kopilov J; Kuksis A Inflamm Res; 2015 Jul; 64(7):497-500. PubMed ID: 25999087 [TBL] [Abstract][Full Text] [Related]
18. Labour is associated with increased expression of type-IIA secretory phospholipase A2 but not type-IV cytosolic phospholipase A2 in human myometrium. Slater DM; Astle S; Bennett PR; Thornton S Mol Hum Reprod; 2004 Nov; 10(11):799-805. PubMed ID: 15361552 [TBL] [Abstract][Full Text] [Related]
19. Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism. Sullivan CP; Seidl SE; Rich CB; Raymondjean M; Schreiber BM J Biol Chem; 2010 Jan; 285(1):565-75. PubMed ID: 19850938 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rho modulates cytokine-induced prostaglandin E2 formation in renal mesangial cells. Petry C; Fritz G; Pfeilschifter J; Huwiler A Biochim Biophys Acta; 2004 Mar; 1636(2-3):108-18. PubMed ID: 15164758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]